RePORT China consortium joined RePORT International in January 2017 after signing the RePORT International Memorandum of Understanding and followed the bylaws, which set clear guidelines and expectations for current and future groups to work together on a broad set of common goals. China consortium developed a locally- tailored study protocol, manual of laboratory operations and case report forms (CRFs) for qualified cases enrollment, sample collection and storage, data collection and sharing based on the Common Protocol and biorepository standards by RePORT International. 7 sites (Beijing, Changsha, Fuzhou, Shanghai, Suzhou, Jingzhou and Zhenjiang) of RePORT China kept active contribution to the sample and data pool. 180 eligible participants set as the target for RePORT China has achieved with the actual number at 198 and samples originated from blood, urine and sputum were collected and stored with the total number at 12480. The 4th RePORT International Meeting was well organized by RePORT China in 2018. 2 projects were successfully funded by RePORT International Supplemental Funding RFP in 2019. “Dynamic detection of cytokines by liquid chip technology to evaluate the efficacy on anti-TB treatment” was hosted by RePORT China and cooperated with RePORT Philippines. The other one is “Pharmacokinetic assessment of MDR-TB drugs in the treatment of TB meningitis” led by Johns Hopkins University and RePORT China was on one of the sites.